uniQure (QURE) announced that the Independent Data Monitoring Committee for EPISOD1, uniQure’s Phase I/II clinical trial of AMT-162, an investigational gene therapy for amyotrophic lateral ...

It may be the middle of winter, but spring is on the horizon for those who await the rebirth of their gardens. Trade thoughts of mugs of cocoa and cozy sweaters for visions of green with a trip to ...

London is a wonderful city to live in, but now and again we all need some time away to enjoy a dose of nature. Fortunately, Londoners are blessed with a wide choice of incredible destinations ...

Now, researchers reporting in ACS Central Science have created a novel treatment that eliminated small breast tumors and significantly shrank large tumors in mice in a single dose, without ...

Of course, some criticize these modern logos as being copy-and-paste, minimalist and unoriginal. Those yearn to return to the unique logos of the 1990s and early 2000s, where the NFL used elements ...

In the ongoing quest to expand semaglutide’s clinical pedigree and cement the GLP-1's market position, Novo Nordisk is rolling out new data on a higher-dose injection in obesity. In the phase 3b ...